A Novel Biomarker for Post-Transplant Recurrent IgA Nephropathy
TRANSPLANTATION PROCEEDINGS, vol.49, no.3, pp.541-545, 2017 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 49 Issue: 3
- Publication Date: 2017
- Doi Number: 10.1016/j.transproceed.2017.02.003
- Journal Name: TRANSPLANTATION PROCEEDINGS
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.541-545
- Istanbul University Affiliated: Yes
Abstract
Background. The serum levels of galactose-deficient immunoglobulin (Ig)A1 (Gd-IgAl) represent the most promising candidate biomarker for IgA nephropathy (IgAN). The aim of this study was to evaluate the serum levels of Gd-IgAl as a novel noninvasive biomarker for post-transplant IgAN recurrence.